As of 3:58pm ET
| +0.0026 / +0.59%|
The 3 analysts offering 12-month price forecasts for Sierra Oncology Inc have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +581.82% increase from the last price of 0.44.
The current consensus among 3 polled investment analysts is to Buy stock in Sierra Oncology Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.